FDA's Opioid Label For Kratom Called Misbranding By Marketers
This article was originally published in The Rose Sheet
Executive Summary
"Based on the scientific information in the literature and further supported by our computational modeling and the reports of its adverse effects in humans, we feel confident in calling compounds found in kratom, opioids," says Commissioner Scott Gottlieb.